REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion

University Hospital, Tours400 enrolled

Overview

The objective of this observational non-randomized multicenter study is to compile real-world clinical characteristics and outcomes data for patients treated with LAA (left atrial appendage) closure systems in a daily clinical setting.

Study Type

OBSERVATIONAL

Enrollment

400

Conditions

Atrial Fibrillation

Interventions

Percutaneous Left Atrial Appendage OcclusionDEVICE

Percutaneous left atrial appendage occlusion in routine care for patients with atrial fibrillation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients who are eligible for a LAA occlusion device and treated with a commercially available device according to international and local guidelines and per physician discretion. Exclusion Criteria: * None

Outcomes

Primary Outcomes

Major adverse cardiovascular events

Death, Ischemic stroke, Transient ischemic attack, Major hemorrhage, Thrombus on device

Time frame: From date of inclusion until the date of first documented event, whichever came first, assessed up to 60 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.